SciELO - Scientific Electronic Library Online

 
vol.53 suppl.4Quality of health care for diabetic and hipertensive patients in primary care settings servicing Mexican Seguro PopularA qualitative approach to drug supply in Mexico: evaluation in the services for population with no medical insurance author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Salud Pública de México

Print version ISSN 0036-3634

Abstract

LOPEZ-MORENO, Sergio et al. Organization of the drug supply chain in state health services: potential consequences of the public-private mix.. Salud pública Méx [online]. 2011, vol.53, suppl.4, pp.445-457. ISSN 0036-3634.

OBJECTIVE. To assess the consequences of private outsourcing on the overall supply and filling of prescriptions in state health services. MATERIAL AND METHODS. The research was conducted using quantitative and qualitative techniques in 13 states. The information was collected through interviews and direct observation. The interviews were carried on staff of state health services related to the drug supply chain and users of health services. The quantitative approach examined the percentage of stocked full recipes in a sample of users. RESULTS States that have opted for the fully outsourced model, and properly monitored this choice, have increased the supply of drugs to their users and guaranteed the supply in the care units in charge. Other states with the outsourced model have multiple problems: direct purchase of drugs not included in the basic drugs catalogue, failure of suppliers and shortage of supplies in the laboratories that provide the company. The main disadvantages identified in all models were: the subordination of the medical criteria to administrative criteria, insufficient planning based on local care needs, heterogeneous procedures, insufficient knowledge of regulations and lack of normativity. CONCLUSION. The results indicate that the incorporation of private providers in the drug supply chain may not be the solution to bring down the shortage faced by health services, especially at the hospital level. The shift to outsourcing models has developed without incorporating evaluation mechanisms and the consequences that this transition can have on state health systems must be investigated more deeply.

Keywords : supply chain management; drugs prescription; Mexico.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License